CIK 0001512762 · Accelerated filer<br>Smaller reporting company
Coherus Oncology, Inc.
Sign in to watch- Ticker
- CHRS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 273615821
- Phone
- (650) 649-3530
- Business address
- C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, 94065
- Former names
- Coherus BioSciences, Inc., BioGenerics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-02-01 | Satvat Ali J. Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2018-02-01 | Lanfear Dennis M See Remarks | Grant or award · Stock Option (Right to Buy) | +400,000 | 400,000 | ||
| 2018-02-01 | Wahlstrom Mats Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2018-02-01 | Richards Christos Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2017-12-15 | Herman Alan C. Chief Scientific Officer | Grant or award | +809 | 50,460 | ||
| 2017-12-15 | FINCK BARBARA K Chief Medical Officer | Grant or award | +7,545 | 34,336 | ||
| 2017-12-15 | Watler Peter K. Chief Technical Officer | Grant or award | +5,900 | 5,900 | ||
| 2017-12-15 | Lanfear Dennis M See Remarks | Grant or award | +20,984 | 92,619 | ||
| 2017-12-15 | Viret Jean-Frederic Chief Financial Officer | Grant or award | +6,966 | 9,958 | ||
| 2017-08-08 | Herman Alan C. Chief Scientific Officer | Sale | −17,535 | $15.02 | $263K | 49,651 |
| 2017-08-06 | Watler Peter K. Chief Technical Officer | Grant or award · Stock Option (Right to Buy) | +67,000 | 67,000 | ||
| 2017-08-06 | Viret Jean-Frederic Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +67,000 | 67,000 | ||
| 2017-08-06 | FINCK BARBARA K Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +67,000 | 67,000 | ||
| 2017-08-06 | Lanfear Dennis M President and CEO | Grant or award · Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2017-07-05 | Herman Alan C. Chief Scientific Officer | Sale | −600 | $15.00 | $9K | 67,186 |
| 2017-06-01 | Herman Alan C. Chief Scientific Officer | Sale | −9,601 | $20.20 | $194K | 69,518 |
| 2017-06-01 | Herman Alan C. Chief Scientific Officer | Sale | −1,732 | $20.98 | $36K | 67,786 |
| 2017-05-17 | Satvat Ali J. Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2017-05-17 | Szela Mary T Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2017-05-17 | LAWLIS V BRYAN Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 |
Page 24 of 39 · 768 trades